Abelacimab prevents VTE after total knee arthroplasty
Jul 26, 2021
Single, postoperative IV dose of abelacimab superior to enoxaparin for preventing venous thromboembolism, with no increase in bleeding risk
ADA: Efpeglenatide lowers risk for adverse CV events in T2DM
Jun 29, 2021
(HealthDay News) — For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based...
ACC: Infected CV implantable electronic devices often not removed
Apr 11, 2022
Although extraction within six days is linked to lower mortality, hardware not removed in 78.9 percent of patients with infected devices
Psychological interventions + physical therapy ease chronic low back pain
Apr 07, 2022
Pain education, behavioral therapy delivered with physical therapy can help with physical function and pain intensity
Guideline addresses diagnosis, evaluation of chest pain in adults
Nov 02, 2021
Chest pain can extend beyond the chest; patients experiencing chest pain or equivalent should seek medical help immediately
Late mortality down for blood or marrow transplant recipients
Sep 14, 2021
Reduction in late mortality strongest for those undergoing transplant when younger than 18 years and for those receiving bone marrow
High demand for at-home COVID-19 tests Could hamper supply, Abbott Says
Aug 30, 2021
Sales have skyrocketed due to the surge in cases driven by the highly transmissible delta variant
AHA: Oral milvexian promising for prevention of VTE
Nov 19, 2021
In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin
FDA: Do not use Dr. Berne’s and LightEyez Eye Drops due to bacteria, fungus
Aug 23, 2023
(HealthDay News) — The U.S. Food and Drug Administration on Tuesday advised people to avoid purchasing and immediately stop using Dr. Berne’s MSM Drops 5 percent Solution and LightEyez MSM...
A-Fib detected in nearly three in 10 cryptogenic stroke patients
Apr 05, 2022
Most patients diagnosed with AF were asymptomatic; arrhythmia detected with 12 months of continuous cardiac monitoring